H&N / Thoracic Radiation Oncologist @WinshipAtEmory. Organ Preservationist. SABR Rattler. Running Enthusiast.

Bill Stokes retweeted
The @RO_Institute Research Committee is looking for new members in 2024. Join us to develop the annual RFP, review grant applications and provide strategic direction for the ROI’s research program. Volunteer at bit.ly/3Lxawwh or learn more at the ROI booth at #ASTRO23.
3
18
2,935
Bill Stokes retweeted
Outstanding talks and debates by our excellent ⁦@WinshipAtEmory⁩ speakers + great visitors, couldn’t miss a min! ⁦@WashingtonUniv⁩ ⁦@MDAndersonNews⁩ ⁦@NikkiSchmittMD⁩ @markmcdonaldmd⁩ ⁦@StokedStokes⁩ ⁦@soumon_rudra⁩ ⁦@ConorSteuerMD⁩
3
14
1,805
This is horrific.
This week’s most viewed articles: 1. Current Causes of Death in Children and Adolescents in the United States nej.md/3Ez4ire #GunViolence
1
266
Querying #lcsm for a friend: Should patients with stage III NSCLC with PD-L1 <1% who complete definitive CRT and do not experience progression receive consolidation durvalumab?
82% yes
18% no
11 votes • Final results
1
263
Subgroup analysis (unplanned) from PACIFIC for consideration: doi.org/10.1016/j.annonc.202…
100
Can inhibitor of apoptosis protein inhibitors (IAPi) succeed in HNSCC where other radiosensitizers have failed? doi.org/10.1002/cam4.6011 Our review covers molecular, preclinical, and clinical aspects of these agents. @NikkiSchmittMD @DrNabilSaba @zach_buchwald
1
4
657
Our phase II single-arm study @WinshipAtEmory is accruing cisplatin-ineligible patients receiving radiotherapy in both definitive and adjuvant settings. All participants receive XRT + tolinapant. clinicaltrials.gov/ct2/show/…
8
155
Bill Stokes retweeted
For those #radonc & #oncology clinics who have integrated an APP-driven survivorship/follow-up model for head and neck cancer #hncsm patients after treatment, how long after RT completion do your pts transition to survivorship? @ASTRO_org
22% 0-3 months after RT
11% 4-12 months after RT
44% >12 months
22% Other (specify in chat)
36 votes • Final results
2
2
5
1,311
Bill Stokes retweeted
Thank you to our patients and the outstanding effort by our very talented @WinshipAtEmory #HNCA team @NikkiSchmittMD @JamesBatesMD @soumon_rudra @StokedStokes @markmcdonaldmd @ConorSteuerMD @JillRemickMD @RamalingamMD @SagarLonialMD
A phase 2 clinical trial led by Winship researchers shows a combination of two drugs was well tolerated and benefitted 91% of participating patients with recurrent/metastatic head and neck squamous cell carcinoma. #hncsm winshipcancer.emory.edu/abou…
3
5
1,498
Excellent review in @JAMAOto of therapeutic vaccines in HNC features this sobering table. For all the recent success with immunotherapy, most patients with R/M HNC: 1) do not respond to ICI, 2) will progress (or die) within 6m, 3) do not live beyond 12m. jamanetwork.com/journals/jam…
1
3
484
(5/6) The myth that surgery offers the only curative treatment for cancer is pervasive in oncology and is a disservice to patients. The field of radiation oncology must do better to educate and advocate. @ASTRO_org
1
4
26
6,571
(6/6) One of my favorite parts of working at @WinshipAtEmory is our H&N Multidisciplinary Clinic, where patients learn about ALL treatment options during their first visit. This allows them to arrive at an informed decision appropriate for their cancer and situation.
8
422
The Adverse Effects of “We Got It All” Amazing commentary in @JAMAOnc about well-intentioned language from surgeons compromising subsequent care. Fortunately, in H&N MDC @WinshipAtEmory, I can counsel pts before surgery about potential adjuvant therapy. jamanetwork.com/journals/jam…
1
2